Clinical perspective highlights multifaceted comorbidity risks in youth with rheumatic diseases, indicating an urgent need for standardized management guidance.
The need for clear, evidence-based guidance on comorbidity management in young people with rheumatic diseases (RDs) is increasingly urgent.1 Individuals with juvenile idiopathic arthritis (JIA), childhood-onset systemic lupus erythematosus (cSLE), and other early-onset systemic inflammatory disorders face a lifelong burden of cardiometabolic, neurocognitive, reproductive, and psychosocial risk.2-4
No takes yet. Share an insight, caveat, or question.
Coziana Ciurtin (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: